Disease-Modifying Therapy in Multiple Sclerosis: Strategies for Optimizing Management
The Neurologist 8:227-236, Frohman,E.,et al, 2002
Lesions of the Corpus Callosum: MR Imaging and Differential Considerations in Adults and Children
AJR 179:251-257, Bourekas,E.C.,et al, 2002
Irreversible Damage to the Spinal Cord Following Spinal Anesthesia
Neurol 59:624-626, Hamandi,K.,et al, 2002
Proposed Diagnostic Criteria and Nosology of Acute Transverse Myelitis
Neurol 59:499-505, Transverse Myelitis Consortium Working Group, 2002
Splinting vs Surgery in the Treatment of Carpal Tunnel Syndrome, A Randomized Controlled Trial
JAMA 288:1245-1251, Gerritsen,A.A.M.,et al, 2002
Out of Africa, Trypanosomiasis
NEJM 347:749-753, Sahlas,D.J.,et al, 2002
Herpes Simplex Encephalitis
JNNP, Kennedy,P.G.E.&Chaudhuri,A., 2002
Tinnitus
NEJM 347:904-910, Lockwood,A.H.,et al, 2002
Risk Factors for Traumatic and Bloody Lumbar Puncture in Children with Acute Lymphoblastic Leukemia
JAMA 288:2001-2007, Howard,S.C., et al, 2002
Infections of Intracardiac Devices
Infect Dis Clin North Am 16:477-505, Karchmer,A.W. &Longworth,D.L., 2002
The Role of Cerebrospinal Fluid Hypocretin Measurement in the Diagnosis of Narcolepsy and Other Hypersomnias
Arch Neurol 59:1553-1562, Mignot,E.,et al, 2002
Progression to Neuropsychological Impairment in Human Immunodeficiency Virus Infection Predicted by Elevated Cerebrospinal Fluid Levels of Human Immunodeficiency Virus RNA
Arch Neurol 59:923-928,909, Ellis,R.J.,et al, 2002
Temporal Arteritis
JAMA 287:2996-3000,3034, Hellmann,D.B., 2002
Is There a Neurologist on the Flight?
Neurol 58:1739-1744,1717, Sirven,J.I.,et al, 2002
Anthrax meningoencephalitis
Neurol 59:327-334,300, Lanska,D.J., 2002
The Final Month of Life in Patients with ALS
Neurol 59:428-431, Ganzini,L.,et al, 2002
Prognosis for Gross Motor Function in Cerebral Palsy
JAMA 288:1357-1363,1399, Rosenbaum,P.L., et al, 2002
Diagnosis of Adult Tuberculous Meningitis by Use of Clinical and Laboratory Features
Lancet 360:1287-1292, Thwaites,G.E.,et al, 2002
Neurologic Presentation of Whipple Disease
Medicine 81:443-457, Gerard,A.,et al, 2002
Occupational Driving and Lumbar Disc Degeneration: A Case-Control Study
Lancet 360:1369-1374, Battie,M.C.,et al, 2002
Two Patients With Unusual Forms of Varicella-Zoster Virus Vasculopathy
NEJM 347:1500-1503, Gilden,D.H.,et al, 2002
The Internet
JNNP 73:619-628, Al-Shahi,R.,et al, 2002
Physician Advice, Patient Actions, and Health-Related Quality of Life in Secondary Prevention of Stroke Through Diet and Exercise
Stroke 33:565-571,570, Greenlund,K.J.,et al, 2002
CSF Evaluation in Primary CNS Lymphoma Patients by PCR of the CDR III IgH Genes
Neurol 58:390-396,339, Gleissner,B.,et al, 2002
Tau Protein and 14-3-3 Protein in the Differential Diagnosis of Creutzfeldt-Jakob Disease
Neurol 58:192-197, Otto,M.,et al, 2002
Peripheral Neuropathy
BMJ 324:466-469, Hughes,R.A.C., 2002
Central Nervous System Infection in Congenital Syphilis
NEJM 346:1792-1798, Michelow,I.C.,et al, 2002
Mycoplasma Pneumoniae Encephalitis in Childhood
J Microbiol Immunol Infect 35:173-178, Lin,W.-C., et al, 2002
Spinal Stroke Syndromes, In Stroke Syndromes, Bougousalsky and Caplan
Chp. 54:691-704, 2nd ed, Sturzenegger, M, 2001
How Neurologists Can Enhance Patient-Centered Medicine
Neurol 56:144-145, Berant,J.L., 2001
A Messy Necessary End
Neurol 56:148-152, Goldblatt,D., 2001
Cerebellar Ataxia With Anti-Glutamic Acid Decarboxylase Antibodies
Arch Neurol 58:225-230, Honorat,J.,et al, 2001
Use of 14-3-3 and Other Brain-specific Proteins in CSF in the Diagnosis of Variant Creutzfeldt-Jakob Disease
JNNP 70:744-748, Green,A.J.E.,et al, 2001
Balo's Concentric Sclerosis: Clinical and Radiologic Features of Five Cases
AJNR 22:1362-1367, Karaarslan,E.,et al, 2001
Cervical MR Imaging in Postural Headache: MR Signs and Pathophysiological Implications
AJNR 22:1239-1250,1233, Yousry,I.,et al, 2001
Neurolymphomatosis of the Lumbar Plexus:High-Resolution MR Neurography Findings
Neurol 57:740-742, Moore,K.R.,et al, 2001
Quantitation of 14-3-3 and Neurol-Specific Enolase Proteins in CSF in Creutzfeldt-Jakob Disease
Neurol 57:728-730, Aksamit,A.L.,et al, 2001
14-3-3 Protein in the CSF as Prognostic Marker in Early Multiple Sclerosis
Neurol 57:722-724, Martinez-Yelamos,A.,et al, 2001
Comtan (Entacapone) The Treatment of Parkinson's Disease, Questions & Answers
APDA Ed Suppl #15, Watts,R.L., 2001
Nonpoliovirus Poliomyelitis Simulating Guillain-Barre Syndrome
Arch Neurol 58:1460-1464, Gorson,K.C.&Ropper,A.H., 2001
Medical Treatment for Neurocysticercosis Characterized by Giant Subarachnoid Cysts
NEJM 345:879-885, Proano,J.V.,et al, 2001
MR Imaging in Comatose Survivors of Cardiac Resuscitation
AJNR 22:1561-1565, Wijdicks,E.F.M.,et al, 2001
Tourette's Syndrome
NEJM 345:1184-1192, Jankovic,J., 2001
The Canadian C-Spine Rule for Radiography in Alert and Stable Trauma Patients
JAMA 286:1841-1848, Stiell,I.G.,et al, 2001
Positron Emission Tomography in Evaluation of Dementia
JAMA 286:2120-2127,2194, Silverman,D.H.S.,et al, 2001
Human Herpesvirus 6 Limbic Encephalitis After Stem Cell Transplantation
Ann Neurol 50:612-619, Wainwright,M.S.,et al, 2001
Oligoclonal Band Number as a Marker for Prognosis in Multiple Sclerosis
Arch Neurol 58:2044-2045, Avasarala,J.R.,et al, 2001
Computed Tomography of the Head Before Lumbar Puncture in Adults With Suspected Meningitis
NEJM 345:1727-1733,1768, Hasbun,R.,et al, 2001
Thrombolysis in Patients with Transient Neurologic Deficits
Neurol 57:2125-2128, Lyden,P.,et al, 2001
CSF Hypocretin/Orexin Levels in Narcolepsy and Other Neurological Conditions
Neurol 57:2253-2258, Ripley,B.,et al, 2001